Lung Connect posted on LinkedIn:
“Revisit practice-changing NSCLC data from two major 2024 conferences.
Dr Herbert Loong shares his views on oncogene-addicted non-small cell lung cancer (NSCLC) data presented at the WCLC and ESMO 2024 congresses.
See more and download the accompanying slides.
The studies mentioned in this update are:
- TRUST-II
- LOXO-RAS-20001
- SOHO-01
- Beamion LUNG-1
- DESTINY-Lung03
- ALKOVE-1
- MARIPOSA
This educational programme is supported by an Independent Educational Grant from Bayer.”
Video attached to the post.